SC 13G | 2018-02-12 | INTRACOASTAL CAPITAL, LLC | OPGEN INC | 268,194 | 5.0% | EDGAR |
SC 13D/A | 2018-02-08 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 347,689 | 6.6% | EDGAR |
SC 13G | 2018-02-08 | Empery Asset Management, LP | OPGEN INC | 461,539 | 9.4% | EDGAR |
SC 13G/A | 2018-01-16 | Empery Asset Management, LP | OPGEN INC | 2,570,000 | 4.7% | EDGAR |
SC 13D/A | 2017-07-25 | jVen Capital, LLC | OPGEN INC | 8,736,808 | 16.7% | EDGAR |
SC 13G | 2017-07-18 | Empery Asset Management, LP | OPGEN INC | 2,500,000 | 5.5% | EDGAR |
SC 13G/A | 2017-01-10 | SABBY MANAGEMENT, LLC | OPGEN INC | 1,083,686 | 5.0% | EDGAR |
SC 13D/A | 2016-08-31 | HARRIS & HARRIS GROUP INC /NY/ | OPGEN INC | 1,092,905 | - | EDGAR |
SC 13D/A | 2016-06-29 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 8,364,270 | 37.5% | EDGAR |
SC 13D/A | 2016-05-31 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 8,364,270 | 37.5% | EDGAR |
SC 13D/A | 2016-05-27 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 8,364,270 | 37.5% | EDGAR |
SC 13D/A | 2016-05-26 | jVen Capital, LLC | OPGEN INC | 4,333,225 | 25.3% | EDGAR |
SC 13G | 2016-05-24 | SABBY MANAGEMENT, LLC | OPGEN INC | 346,014 | 2.1% | EDGAR |
SC 13D | 2015-07-23 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 1,479,022 | 11.8% | EDGAR |
SC 13D | 2015-05-14 | HARRIS & HARRIS GROUP INC /NY/ | OPGEN INC | 1,710,629 | - | EDGAR |
SC 13D | 2015-05-14 | jVen Capital, LLC | OPGEN INC | 3,375,685 | - | EDGAR |
SC 13D | 2015-05-14 | Versant Ventures III, LLC | OPGEN INC | 2,973,950 | - | EDGAR |